AI-assisted workflows for PBPK modeling

PBPK modeling is central to how modern drug development teams explore dosing, safety, and candidate behavior before expensive trials. The work is deeply technical, highly regulated in spirit, and often spread across tools, data sources, and expert review steps.

Emergence AI needed a product direction that reduced friction in that chain. Manual handoffs, inconsistent review paths, and fragmented context make it hard to keep momentum. The goal was not to replace scientific judgment, but to give teams a structured, repeatable workflow that keeps everyone aligned and accelerates the review cycle.

Without a coherent system, the risk was continued slow iteration, duplicated effort, and difficulty scaling the product story to serious pharmaceutical users who expect rigor and traceability.

We delivered a multi-agent system that automates and coordinates the end-to-end PBPK modeling workflow. Specialized agents handle distinct parts of the pipeline while a clear orchestration layer keeps state, handoffs, and outputs consistent.

The experience is built so human experts remain in control: agents propose steps, assemble context, and prepare artifacts for review rather than bypassing governance. That balance matters in a domain where explainability and auditability are as important as raw speed.